Piero Olliaro, Josie Bourner, Alex Salam, Mihaja Raberahona, and Rindra Vatosoa Randremanana

Piero Olliaro is the Director of Science of the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) and Professor of Poverty Related Infectious Diseases at the University of Oxford. Piero is responsible for the implementation and support of ISARIC’s clinical research programme, including projects on plague, Lassa fever, COVID-19 and monkeypox.

Josie Bourner is the Clinical Trials Manager of the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). Josie is responsible for the management of several projects within ISARIC’s clinical research programme, including projects on plague, Lassa fever and monkeypox. Josie is also a DPhil student at the University of Oxford studying clinical trial methodology for rare emerging infections.

Alex Salam is a Specialist Registrar in Infectious Disease and General Internal Medicine. He was a Clinical Advisor at the Save the Children Kerry Town Ebola treatment centre (ETC) and subsequently Medical Director at the GOAL Port Loko ETC during the West African Ebola outbreak in Sierra Leone. Alex is a clinical researcher on the UK Public Health Rapid Support Team (UK-PHRST), and is part of the core deployable team.

Mihaja Raberahona is a clinical practitioner and infectious disease researcher at the University Hospital Joseph Raseta Befelatanana and Centre Infectiologie Charles Mérieux in Antananarivo, Madagascar. His research focus includes plague, HIV and tuberculosis.

Rindra Vatosoa Randremanana is the Head of the Epidemiology and Clinical Research Unit at the Institut Pasteur de Madagascar in Antananarivo. Rindra oversees the epidemiology and clinical research programme, including projects on plague, infant malnutrition and tuberculosis.

All authors are part of the IMASOY trial team.

Latest posts by Piero Olliaro, Josie Bourner, Alex Salam, Mihaja Raberahona, and Rindra Vatosoa Randremanana (see all)